Search

Search Constraints

You searched for: Author/Creator Dionne, Marc

Search Results

1. Characterization and evolution of infection control practices among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)–infected healthcare workers in acute-care hospitals and long-term care facilities in Québec, Canada, Spring 2020. (15th April 2022)

2. Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial. Issue 9 (September 2021)

3. Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial. (6th September 2019)

4. Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. (3rd February 2019)

5. P471 Lymphogranuloma venerum in Quebec, Canada: five years of epidemiological survey, 2013–2017. (14th July 2019)

6. Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults. Issue 9 (2nd June 2019)

7. Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus. Issue 8 (2nd August 2016)

8. Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study. Issue 1 (2nd January 2016)

9. The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70. (20th July 2021)